A Committee-Based Diagnostic Stewardship Model for Pathogen Metagenomic Sequencing in Children
The Journal of Applied Laboratory Medicine · 2025
DOI: 10.1093/jalm/jfae084 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, 2025. Verfasst von Brian S Allen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Infectious Diseases, University of Missouri School of Medicine, Columbia, MO, United States. Hauptthemen laut MEDLINE: Metagenomics, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Metagenomic next-generation sequencing (mNGS) for pathogen detection offers the potential for broad pathogen detection directly from clinical specimens. However, the yield and impact of testing is variable, financial cost is high, and questions surrounding its optimal use remain. Our pediatric institution used a clinical committee-based approach to discuss and approve or deny mNGS test requests. In this study, we evaluate the patient characteristics for which mNGS testing was considered, test yield, and clinical impact of mNGS results when employing this model of diagnostic stewardship.
Methods
Patients for which plasma cell-free DNA mNGS testing was requested and assessed by the clinical committee between August 1, 2018, and April 30, 2021, were included. The committee discussion emails were used to evaluate reasons for making the test request and treatment plans. Patient characteristics and additional clinical information were gathered by chart review. For approved cases, the clinical impact of the mNGS results were retrospectively adjudicated by infectious disease and clinical microbiology experts.
Results
Twelve requests for plasma cell-free DNA mNGS were evaluated and 9 were approved. mNGS results led to a positive clinical management change in 55% of approved requests. Negative clinical impact of mNGS testing did not occur during the study. The patients for which testing requests were denied had resolution of symptoms without further intervention.
Conclusions
This committee-based test request approval diagnostic stewardship model has the potential to support high-yield mNGS testing while using healthcare resources responsibly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Infectious Diseases, University of Missouri School of Medicine, Columbia, MO, United States.
- Department of Pediatrics, Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX, United States.
- Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, United States.
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Zitieren
APA
Allen, B. S., Kidd, M., Sue, P. K., & Filkins, L. M. (2025). A Committee-Based Diagnostic Stewardship Model for Pathogen Metagenomic Sequencing in Children. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfae084
Vancouver
Allen BS, Kidd M, Sue PK, Filkins LM. A Committee-Based Diagnostic Stewardship Model for Pathogen Metagenomic Sequencing in Children. The Journal of Applied Laboratory Medicine. 2025. doi:10.1093/jalm/jfae084
BibTeX
@article{Allen2025,
author = {Allen, Brian S and Kidd, Mehgan and Sue, Paul K and Filkins, Laura M},
title = {A Committee-Based Diagnostic Stewardship Model for Pathogen Metagenomic Sequencing in Children},
journal = {The Journal of Applied Laboratory Medicine},
year = {2025},
doi = {10.1093/jalm/jfae084}
}
EUVIMED